Manulife (Manufacturers Life Insurance)’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,729
| Closed | -$203K | – | 2974 |
|
|
2024
Q3 | $203K | Sell |
8,729
-219
| -2% | -$5.08K | ﹤0.01% | 2663 |
|
|
2024
Q2 | $218K | Buy |
8,948
+262
| +3% | +$6.38K | ﹤0.01% | 2571 |
|
|
2024
Q1 | $293K | Sell |
8,686
-149
| -2% | -$5.03K | ﹤0.01% | 2407 |
|
|
2023
Q4 | $279K | Sell |
8,835
-256
| -3% | -$8.07K | ﹤0.01% | 2441 |
|
|
2023
Q3 | $232K | Sell |
9,091
-167
| -2% | -$4.27K | ﹤0.01% | 2509 |
|
|
2023
Q2 | $266K | Buy |
9,258
+681
| +8% | +$19.5K | ﹤0.01% | 2443 |
|
|
2023
Q1 | $206K | Buy |
+8,577
| New | +$206K | ﹤0.01% | 2552 |
|
|
2022
Q2 | – | Sell |
-8,352
| Closed | -$225K | – | 3012 |
|
|
2022
Q1 | $225K | Sell |
8,352
-2,179
| -21% | -$58.7K | ﹤0.01% | 2692 |
|
|
2021
Q4 | $390 | Sell |
10,531
-24
| -0.2% | -$1 | ﹤0.01% | 2432 |
|
|
2021
Q3 | $504K | Sell |
10,555
-1,231
| -10% | -$58.8K | ﹤0.01% | 2279 |
|
|
2021
Q2 | $399K | Buy |
11,786
+789
| +7% | +$26.7K | ﹤0.01% | 2592 |
|
|
2021
Q1 | $454K | Sell |
10,997
-1,680
| -13% | -$69.4K | ﹤0.01% | 2344 |
|
|
2020
Q4 | $550K | Buy |
12,677
+3,895
| +44% | +$169K | ﹤0.01% | 2141 |
|
|
2020
Q3 | $377K | Buy |
8,782
+1,224
| +16% | +$52.5K | ﹤0.01% | 2142 |
|
|
2020
Q2 | $355K | Buy |
+7,558
| New | +$355K | ﹤0.01% | 2137 |
|